Fundz

Who to call at Apellis Pharmaceuticals, and when

Fundz watches for the moments Apellis Pharmaceuticals starts buying, and tells you who to reach.

  • An alert the day Apellis Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Apellis Pharmaceuticals, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

LaunchApellis Pharmaceuticals announces the approval of SYFOVRE® for geographic atrophy treatment in Australia.

Jan 27, 2025
WalthamBiotechnologyHealthcareHealth CareTherapeuticsPharmaceuticalBiopharma

Product Description

Apellis Pharmaceuticals has received approval from the Therapeutic Goods Administration in Australia for SYFOVRE®, the first treatment for geographic atrophy, providing hope to many affected patients.

Company Information

Company

Apellis Pharmaceuticals

Location

6400 WESTWIND WAY

Waltham, Massachusetts, United States

About

Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that combines courageous science and compassion to develop life-changing therapies for some of the most challenging diseases patients face.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Apellis Pharmaceuticals ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Apellis Pharmaceuticals's next move

Learn about Strategic plan

Product Launch Insights

What this usually means
Market expansion signals
New product launches often coincide with market expansion initiatives

Apellis Pharmaceuticals shipped something new. Fundz reads product launches, trademark filings and hiring together.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.